Immunological techniques in viral hepatitis

Journal of Hepatology

Volumn 46, Issue 3, 2007, Pages 508-520

  Rehermann, Barbara ^a   Naoumov, Nikolai V ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antibody; B cell; Dendritic cell; ELISpot; Hepatitis B virus; Hepatitis C virus; Lymphocyte; Proliferation; T cell; Vaccine

Indexed keywords

CYTOKINE; HEPATITIS C ANTIBODY;

ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL IMMUNOLOGY; CLINICAL PROTOCOL; CYTOTOXICITY TEST; DENDRITIC CELL; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; FREEZING; FUNCTIONAL ASSESSMENT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL PROCEDURES; IMMUNOTHERAPY; LABORATORY TEST; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STANDARDIZATION; T LYMPHOCYTE; THAWING; VIRUS HEPATITIS;

ANTIBODIES, VIRAL; B-LYMPHOCYTES; ENDPOINT DETERMINATION; GREAT BRITAIN; HEPATITIS B; HEPATITIS C; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC TECHNIQUES; KILLER CELLS, NATURAL; PHENOTYPE; T-LYMPHOCYTES;

EID: 33846603181     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.01.002     Document Type: Article

References (77)

1. Ferrari C., Mondelli M.U., Penna A., Faccadori F., and Chisari F.V. Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines. J Immunol 139 (1987) 539-544
2. Barnaba V., Franco A., Alberti A., Balsano C., Benvenuto R., and Balsano F. Recognition of hepatitis B envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. J Immunol 143 (1989) 2650-2655
3. Mondelli M.U., Chisari F.V., and Ferrari C. The cellular immune response to nucleocapsid antigens in hepatitis B virus infection. Springer Semin Immunopathol 12 (1990) 25-31
4. Diepolder H.M., Gerlach J.-T., Zachoval R., Hoffmann R.M., Jung M.C., Wierenga E.A., et al. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol 71 (1997) 6011-6019
5. Cooper S., Erickson A.L., Adams E.J., Kansopon J., Weiner A.J., Chien D.Y., et al. Analysis of a successful immune response against hepatitis C virus. Immunity 10 (1999) 439-449
6. Erickson A.L., Kimura Y., Igarashi S., Eichelberger J., Houghton M., Sidney J., et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity 15 (2001) 883-895
7. Bertoletti A., Ferrari C., Fiaccadori F., Penna A., Margolskee R., Schlicht H.J., et al. HLA class-I restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci USA 88 (1991) 10445-10449
8. Koziel M.J., Dudley D., Wong J.T., Dienstag J., Houghton M., Ralston R., et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 149 (1992) 3339-3344
9. Barnaba V., Franco A., Alberti A., Benvenuto R., and Balsano F. Selective killing of hepatitis B envelope antigen-specific B cells by class I restricted, exogenous antigen specific T lymphocytes. Nature 345 (1990) 258-260
10. Koziol J.A., Ferrari C., and Chisari F.V. Evaluation of monoclonality of cell lines from sequential dilution assays. J Immunol Methods 105 (1987) 139-143
11. Rehermann B., Chang K.M., McHutchison J.G., Kokka R., Houghton M., and Chisari F.V. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response, disease activity and viral load in patients with chronic hepatitis C virus infection. J Clin Invest 98 (1996) 1432-1440
12. Lechner F., Wong D.K., Dunbar P.R., Chapman R., Chung R.T., Dohrenwend P., et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191 (2000) 1499-1512
13. Day C.L., Lauer G.M., Robbins G.K., McGovern B., Wurcel A.G., Gandhi R.T., et al. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J Virol 76 (2002) 12584-12595
14. Lauer G.M., Ouchi K., Chung R.T., Nguyen T.N., Day C.L., Purkis D.R., et al. Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J Virol 76 (2002) 6104-6113
15. Maecker H.T., Moon J., Bhatia S., Ghanekar S.A., Maino V.C., Payne J.K., et al. Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT. BMC Immunol 6 (2005) 17
16. Garcia-Pineres A.J., Hildesheim A., Williams M., Trivett M., Strobl S., and Pinto L.A. DNAse treatment following thawing of cryopreserved PBMC is a procedure suitable for lymphocyte functional studies. J Immunol Methods 313 (2006) 209-213
17. Czerkinsky C.C., Nilsson L.A., Nygren H., Ouchterlony O., and Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 65 (1983) 109-121
18. Czerkinsky C., Andersson G., Ekre H.P., Nilsson L.A., Klareskog L., and Ouchterlony O. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J Immunol Methods 110 (1988) 29-36
19. Gazagne A., Claret E., Wijdenes J., Yssel H., Bousquet F., Levy E., et al. A Fluorospot assay to detect single T lymphocytes simultaneously producing multiple cytokines. J Immunol Methods 283 (2003) 91-98
20. Kreher C.R., Dittrich M.T., Guerkov R., Boehm B.O., and Tary-Lehmann M. CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays. J Immunol Methods 278 (2003) 79-93
21. Karulin A.Y., Hesse M.D., Tary-Lehmann M., and Lehmann P.V. Single-cytokine-producing CD4 memory cells predominate in type 1 and type 2 immunity. J Immunol 164 (2000) 1862-1872
22. McCutcheon M., Wehner N., Wensky A., Kushner M., Doan S., Hsiao L., et al. A sensitive ELISPOT assay to detect low-frequency human T lymphocytes. J Immunol Methods 210 (1997) 149-166
23. Maecker H.T., Dunn H.S., Suni M.A., Khatamzas E., Pitcher C.J., Bunde T., et al. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J Immunol Methods 255 (2001) 27-40
24. Draenert R., Altfeld M., Brander C., Basgoz N., Corcoran C., Wurcel A.G., et al. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. J Immunol Methods 275 (2003) 19-29
25. Firbas C., Jilma B., Tauber E., Buerger V., Jelovcan S., Lingnau K., et al. Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects. Vaccine 24 (2006) 4343-4353
26. Wedemeyer H., He X.-S., Nascimbeni M., Davis A.R., Greenberg H.B., Hoofnagle J.H., et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169 (2002) 3447-3458
27. Guerkov R.E., Targoni O.S., Kreher C.R., Boehm B.O., Herrera M.T., Tary-Lehmann M., et al. Detection of low-frequency antigen-specific IL-10-producing CD4(+) T cells via ELISPOT in PBMC: cognate vs. nonspecific production of the cytokine. J Immunol Methods 279 (2003) 111-121
28. Nylander S., and Kalies I. Brefeldin A, but not monensin, completely blocks CD69 expression on mouse lymphocytes: efficacy of inhibitors of protein secretion in protocols for intracellular cytokine staining by flow cytometry. J Immunol Methods 224 (1999) 69-76
29. Suni M.A., Dunn H.S., Orr P.L., de Laat R., Sinclair E., Ghanekar S.A., et al. Performance of plate-based cytokine flow cytometry with automated data analysis. BMC Immunol 4 (2003) 9
30. Riedy M.C., Muirhead K.A., Jensen C.P., and Stewart C.C. Use of a photolabeling technique to identify nonviable cells in fixed homologous or heterologous cell populations. Cytometry 12 (1991) 133-139
31. King M.A. Detection of dead cells and measurement of cell killing by flow cytometry. J Immunol Methods 243 (2000) 155-166
32. Fetterhoff T., Holland S., and Wile K. Fluorescent detection of non-viable cells in fixed cell preparations. Cytometry Suppl. 6 (1993) 27
33. Day C.L., Seth N.P., Lucas M., Appel H., Gauthier L., Lauer G.M., et al. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Invest 112 (2003) 831-842
34. Maini M.K., Boni C., Lee C.K., Larrubia J.R., Reignat S., Ogg G.S., et al. The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus (HBV) infection. J Exp Med 191 (2000) 1269-1280
35. He X.-S., Rehermann B., Lopez-Labrador F.X., Boisvert J., Cheung R., Mumm J., et al. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci USA 96 (1999) 5692-5697
36. Accapezzato D., Francavilla V., Paroli M., Casciaro M., Chircu L.V., Cividini A., et al. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 113 (2004) 963-972
37. Ulsenheimer A., Lucas M., Seth N.P., Tilman Gerlach J., Gruener N.H., Loughry A., et al. Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses. J Viral Hepat 13 (2006) 708-714
38. Ferrari C., Penna A., Bertoletti A., Valli A., Antoni A.D., Giuberti T., et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 145 (1990) 3442-3449
39. Vento S., Rondanelli E.G., Ranieri S., O'Brien C.J., Williams R., and Eddleston A.L. Prospective study of cellular immunity to hepatitis-B-virus antigens from the early incubation phase of acute hepatitis B. Lancet 2 (1987) 119-122
40. Diepolder H.M., Zachoval R., Hoffmann R.M., Wierenga A., Santantonio T., Jung M.-C., et al. Possible mechanism involving T lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346 (1995) 1006-1007
41. Rigopoulou E.I., Suri D., Chokshi S., Mullerova I., Rice S., Tedder R.S., et al. Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity. Hepatology 42 (2005) 1028-1036
42. Harari A., Dutoit V., Cellerai C., Bart P.A., Du Pasquier R.A., and Pantaleo G. Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev 211 (2006) 236-254
43. Liu L., Chahroudi A., Silvestri G., Wernett M.E., Kaiser W.J., Safrit J.T., et al. Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates. Nat Med 8 (2002) 185-189
44. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281 (2003) 65-78
45. Shafer-Weaver K., Rosenberg S., Strobl S., Gregory Alvord W., Baseler M., and Malyguine A. Application of the granzyme B ELISPOT assay for monitoring cancer vaccine trials. J Immunother 29 (2006) 328-335
46. Zuber B., Levitsky V., Jonsson G., Paulie S., Samarina A., Grundstrom S., et al. Detection of human perforin by ELISpot and ELISA: ex vivo identification of virus-specific cells. J Immunol Methods 302 (2005) 13-25
47. Wolint P., Betts M.R., Koup R.A., and Oxenius A. Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells. J Exp Med 199 (2004) 925-936
48. Koziel J.M., Dudley D., Afdhal N., Choo Q.L., Houghton M., Ralston R., et al. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 67 (1993) 7522-7532
49. Bertoletti A., Sette A., Chisari F.V., Penna A., Levrero M., De Carli M., et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369 (1994) 407-410
50. Chang K.M., Rehermann B., McHutchison J.G., Pasquinelli C., Southwood S., Sette A., et al. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. J Clin Invest 100 (1997) 2376-2385
51. Meyer-Olson D., Shoukry N.H., Brady K.W., Kim H., Olson D.P., Hartman K., et al. Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J Exp Med 200 (2004) 307-319
52. Urbani S., Amadei P., Fisicaro P., Massimo P., Missale G., Bertoletti A., et al. Heterologous T cell immunity in severe hepatitis C virus (HCV) infection. J Exp Med 201 (2005) 675-680
53. Rosa D., Saletti G., De Gregorio E., Zorat F., Comar C., D'Oro U., et al. Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci USA 102 (2005) 18544-18549
54. Bernasconi N.L., Traggiai E., and Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298 (2002) 2199-2202
55. Poeck H., Wagner M., Battiany J., Rothenfusser S., Wellisch D., Hornung V., et al. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood 103 (2004) 3058-3064
56. Bartosch B., Dubuisson J., and Cosset F.L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 197 (2003) 633-642
57. Hsu M., Zhang J., Flint M., Logvinoff C., Cheng-Mayer C., Rice C.M., et al. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA 100 (2003) 7271-7276
58. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., et al. Complete replication of hepatitis C virus in cell culture. Science 309 (2005) 623-626
59. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11 (2005) 791-796
60. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102 (2005) 9294-9299
61. Dreux M., Pietschmann T., Granier C., Voisset C., Ricard-Blum S., Mangeot P.E., et al. High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI. J Biol Chem 281 (2006) 18285-18295
62. Voisset C., Op de Beeck A., Horellou P., Dreux M., Gustot T., Duverlie G., et al. High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry. J Gen Virol 87 (2006) 2577-2581
63. Tang K.H., Herrmann E., Cooksley H., Tatman N., Chokshi S., Williams R., et al. Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy. J Hepatol 43 (2005) 776-782
64. Mullan B., Kenny-Walsh E., Collins J.K., Shanahan F., and Fanning L.J. Inferred hepatitis C virus quasispecies diversity is influenced by choice of DNA polymerase in reverse transcriptase-polymerase chain reactions. Anal Biochem 289 (2001) 137-146
65. Smith D.B., McAllister J., Casino C., and Simmonds P. Virus 'quasispecies': making a mountain out of a molehill?. J Gen Virol 78 Pt 7 (1997) 1511-1519
66. Kwok S., and Higuchi R. Avoiding false-positives with polymerase chain reaction. Nature 339 (1989) 237-238
67. Bradley R.D., and Hillis D.M. Recombinant DNA sequences generated by PCR amplification. Mol Biol Evol 14 (1997) 592-593
68. Liu S.L., Rodrigo A.G., Shankarappa R., Learn G.H., Hsu L., Davidov O., et al. HIV quasispecies and resampling. Science 273 (1996) 415-416
69. Simmonds P., Bukh J., Combet C., Deleage G., Enomoto N., Feinstone S., et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42 (2005) 962-973
70. Vogelstein B., and Kinzler K.W. Digital PCR. Proc Natl Acad Sci USA 96 (1999) 9236-9241
71. Ray S.C., Fanning L., Wang X.H., Netski D.M., Kenny-Walsh E., and Thomas D.L. Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J Exp Med 201 (2005) 1753-1759
72. Cox A.L., Mosbruger T., Mao Q., Liu Z., Wang X.H., Yang H.C., et al. Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 201 (2005) 1741-1752
73. MacDonald H.R. NK1.1+ T cell receptor-alpha/beta+ cells: new clues to their origin, specificity, and function. J Exp Med 182 (1995) 633-638
74. Bendelac A., Lantz O., Quimby M.E., Yewdell J.W., Bennink J.R., and Brutkiewicz R.R. CD1 recognition by mouse NK1+ T lymphocytes. Science 268 (1995) 863-865
75. Emoto M., and Kaufmann S.H. Liver NKT cells: an account of heterogeneity. Trends Immunol 24 (2003) 364-369
76. Exley M., and Koziel M. To be or not to be NKT: Natural killer T cells in the liver. Hepatology 40 (2004) 1033-1040
77. Scheibenbogen C., Romero P., Rivoltini L., Herr W., Schmittel A., Cerottini J.C., et al. Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial. J Immunol Methods 244 (2000) 81-89